4/17
08:30 am
inbs
Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified
Medium
Report
Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified
4/11
01:00 am
inbs
Neutral
Report
4/2
08:30 am
inbs
Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market
High
Report
Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market
3/26
08:30 am
inbs
Intelligent Bio Solutions Strengthens European IP Portfolio with Eighth Patent Grant
Low
Report
Intelligent Bio Solutions Strengthens European IP Portfolio with Eighth Patent Grant
2/25
08:45 am
inbs
Intelligent Bio Solutions Successfully Manufactures and Ships First Readers with New Partner, Accelerating Scale and Driving Gross Margin Expansion in Anticipation of Planned U.S. Entry
High
Report
Intelligent Bio Solutions Successfully Manufactures and Ships First Readers with New Partner, Accelerating Scale and Driving Gross Margin Expansion in Anticipation of Planned U.S. Entry
2/24
08:45 am
inbs
Intelligent Bio Solutions Partners with Bouygues UK, Part of Multi-Billion Dollar Global Construction Giant Bouygues Construction, for UK Drug Testing Rollout
High
Report
Intelligent Bio Solutions Partners with Bouygues UK, Part of Multi-Billion Dollar Global Construction Giant Bouygues Construction, for UK Drug Testing Rollout
2/12
08:30 am
inbs
Intelligent Bio Solutions Reports Record Fiscal Second Quarter Revenue Growth of 48% with Reader Sales Surging 104% Year-Over-Year
High
Report
Intelligent Bio Solutions Reports Record Fiscal Second Quarter Revenue Growth of 48% with Reader Sales Surging 104% Year-Over-Year
2/5
08:30 am
inbs
Intelligent Bio Solutions Expects to Report Fiscal Second Quarter 2026 Revenue Growth of Approximately 48% Year-Over-Year, Surpassing $2 Million in Total Revenue for First Half of Fiscal Year
High
Report
Intelligent Bio Solutions Expects to Report Fiscal Second Quarter 2026 Revenue Growth of Approximately 48% Year-Over-Year, Surpassing $2 Million in Total Revenue for First Half of Fiscal Year
1/31
01:33 am
inbs
Intelligent Bio Solutions (NASDAQ:INBS) was upgraded by analysts at
Wall
Medium
Report
Intelligent Bio Solutions (NASDAQ:INBS) was upgraded by analysts at
Wall
1/28
08:30 am
inbs
Intelligent Bio Solutions Initiates Additional Clinical Studies for FDA 510(k) Submission Supporting Planned Entry into Multi-Billion Dollar U.S. Market
Low
Report
Intelligent Bio Solutions Initiates Additional Clinical Studies for FDA 510(k) Submission Supporting Planned Entry into Multi-Billion Dollar U.S. Market
1/24
05:08 am
inbs
Intelligent Bio Solutions (NASDAQ:INBS) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Intelligent Bio Solutions (NASDAQ:INBS) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.